Division of Clinical Pharmacology Archive — Page 3 of 4

Sara Van Driest, MD, PhD, with Dan Roden, MD, who nominated her for the award from the American Society of Clinical Pharmacology and Therapeutics.
May 22, 2019

Van Driest lands young investigator award from the American Society for Clinical Pharmacology and Therapeutics

Sara Van Driest, MD, PhD, assistant professor of Pediatrics and Medicine, recently received the 2019 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics.

April 4, 2019

Harvard’s Gaziano set for April 11 clinical pharmacology lecture

J. Michael Gaziano, MD, MPH, an internationally recognized chronic disease epidemiologist, will deliver the 15th annual Grant R. Wilkinson Distinguished Lectureship in Clinical Pharmacology on Thursday, April 11.

Head-and-shoulders portrait of a smiling man in a suit and patterned tie against a neutral background.
November 15, 2018

Harrison awarded AHA Basic Research Prize for 2018

David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.

Manual blood pressure monitor with a blue cuff, round pressure gauge, black inflation bulb, and attached stethoscope on a white background.
September 27, 2018

Stretch, inflammation and hypertension

New research sheds light on how changes in blood vessel forces enhance immune cell activation and promote hypertension.

Three adults pose together indoors: a woman in a gray jacket, a man in a blue shirt, and an older man in a dark suit with a patterned tie.
September 6, 2018

Link between immune system, disease explored

The first Flexner Discovery Lecture of the academic year featured presentations by two Vanderbilt faculty members.

April 19, 2018

Former FDA official explores big data’s impact on healthcare

“Big data” can help reverse the alarming decline in life expectancy in the United States — if universities and academic medical centers take the lead, former U.S. Food and Drug Administrator Robert Califf, MD, told a Vanderbilt audience last week.